tirzepatide wichita ks Weight Loss Injections in Tirzepatide Flex-Dose 1 mL Injectable

2021;16(3):e0246747

It affects neural cell signaling and how your body uses energy

Low B12 levels are often linked with symptoms of depression and cognitive issues

not yet FDA-approved for any population Best adult efficacy / 24.2% mean weight loss at 48 weeks (12 mg dose, Phase 2) [1] Adolescent trial data / none published as of May 2026 Primary safety signals in adults / nausea, diarrhea, vomiting, decreased appetite [1] Growth concern / caloric restriction during puberty may slow linear growth velocity Mental-health watch / depression, suicidal ideation screening recommended per FDA adolescent obesity guidance Comparator precedent / semaglutide 2.4 mg studied in STEP TEENS (ages 12, 17) with a similar GI side-effect profile [2] Monitoring minimum / Tanner staging, height velocity, bone-age films, PHQ-A at each visit Why Adolescent Safety Data for Retatrutide Does Not Yet Exist No peer-reviewed trial has enrolled patients aged 12 to 17 for retatrutide as of May 2026

Tan says